Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ZZZZ....glad i got in this one. Ready to get out today or tomorrow.
35 min. since the last trade
Supposedly a 6 million float.. gl on large blocks
I purchased yesterday..GL on getting filled...eom
Can't get filled for 100K at .05, all or none
All or none, gl. Hopefully you make this baby rock
Scratch that, this is a pump and dump.... .02 if you want to wait, probably tomorrow.
Trying to buy 100K at .05, all or none
I would say .035, but your .05 is a lot better than my 9
Is 5 cents a good entry point? Or what do you guys think is the maximum I should pay per share to get into this stock?
Thanks.
Found this on another message forum:
Remember Folks, BPMA operates 5 Drug Plants, could be that the Chinese Government or someone asked them to help in making Swine Flu Vaccines.
There are some ongoing concerned about the shortage of Swine Flu Vaccines around the Globe.
Stace
China Biopharma Growing at "China Speed" BPMA BPMA
In China biopharma news last week, there were two items of broad significance and a host of company-specific announcements. The pace of growth in China biopharma seems to be picking up, as the industry lives up to the often used term “China Speed.”
Perhaps the report with the most far-reaching significance was a story about the as-yet unannounced 11 billion RMB ($1.5 billion) initiative of China’s government to stimulate a native innovative drug sector (see story). China’s cabinet, the State Council, is reported to have approved the program in late December, but has not made any formal declarations about the plan so far.
Benda Pharmaceutical (BPMA.OB) will seek to migrate from the OTC Bulletin Board to the American Stock Exchange (see story) . The company has also established a relationship with CRT Capital Group LLC to explore strategic alternatives, including M&A, joint venture, divestiture, spin-off, financing or other capital market transactions, a companion initiative to the AMEX listing. In April 2007, Benda bought a 60% share of SiBiono and its gene therapy cancer drug Gendicine. Part of the deal sent 2.2 million unregistered shares to SiBiono owners. Benda promised the investors that the shares would be registered on the NASDAQ or AMEX and that they would have a price of $3.60 each by mid-2008.
Stace
This is good consolidation and folks are now aware of this gem.
Not the least bit worried, although I had hoped for a run to 15 today.
I can wait.
Stace
Think Positive!!
Stace
I agree going to lunch hope to see green when I get back
Dumb Arse traders that have little to no compassion for their fellow traders.
I hate Bid Whackers!
Stace
Nice consolidation here, healthy. Should run later.
Hell they could make a half a penney more per share at the ask
Yeah, we had a bid at .065 until some DB whacked it.
Stace
BMs at 38 now.
I am still optimistic!
Stace
I have to admit to being a .09 buyer, but I went in small enough that I can average down. After reviewing the SEC filings, and know how MMs work, something is definitely cooking
Bidding .05
We had 65/7 and some Douche whacked it!
Stace
Keep my mouth shut! LOL
Stace
.052 x .065 2x1...selling looks dried up..let's take it up from here...
Damn Whackers!!!!
Stace
You will be.
Patience my man!
Stace
Here we go guys!
Closing at 10 today!
Stace
lol I'm not at .10 yet : )
I knew it.
You owe me a high five!
Stace
yeppers no profit left below 05 new base
"the world’s first commercialized gene therapy medicine for the treatment of cancer"
Stace
Yeah, I noticed. The selling (whoever it was) is gone.
Now we go up.
Stace
MMs helped to walk this down was on the bid at 06 they went rite by and filled at 055 this will go rite back up. Flippers will be on this heavy till .20 jmop
Agree TT.
Watching Level 2 as we speak.
Please sell at ASK if you must sell.
Thanks,
Stace
I saw this in PMAH and a bunch of others.
I got more today at .06 and I still say we close right at 10 and then go North from there.
It is all about strong hands.
Stace
Two MM's at .05 on bid. 1 at .07 at ask.
The ask is still thin. If the sellers are truly gone then the bid will build back up.
Layla
They don't want it to run yet. MM's were filling at the bid when my order was above the ask yesterday making it look like bid whacking. Messed up.
We have all seen this before after a huge run up.
I am glued to Level 2 and the selling looks to be over.
I see the bids increasing and the ask getting taken out all the way .10.
I bet you I am right!
Stace
l continue to
Stace
The O/S is still at 105M today. No change.
Stace
I will give you a high five if it does.
Not looking too good.
Looks like the sellers are done.
I still say we break 10 today.
Stace
Capacity Expanded at Benda Pharmaceutical; Expects Revenue to Jump
Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTCBB:BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced today that its Ebei plant received Good Manufacturing Practices (GMP) certification for its new tablets product line on November 26, 2007. The GMP certification clears the tablets for mass production and sale, marking the official conclusion of the plant’s dramatic capacity expansion and beginning its significant product line growth.
The Ebei plant is currently Benda’s most significant revenue contributor and forms the solid base upon which Benda is launching next generation biopharmaceuticals like Gendicine®. Ebei achieved $11.8 MM in revenue during the first nine months of 2007, a 55% increase over the same period a year ago. The Ebei plant has been primarily engaged in producing and distributing conventional medicines in injection vial form.
To both grow and diversify the plant’s business, Benda began in September 2006 the construction of an addition to the plant intended to house multiple new production lines. The Company completed construction in September 2007. The new addition adds to the product mix five new production lines, with respective annual capacities of 40 million oral liquid vials, 230 million capsules, 758 million tablets, 500 tons of pills and 20 million bags of granules.
On November 26, 2007 the tablets line became the first to receive GMP certification, valid for a 5-year period. The Ebei plant will initiate the full production and sale of tablets in late December 2007; Benda expects the new tablets line alone to contribute approximately $1.8 million in revenue in 2008. The four remaining product lines are all under GMP review and the Company expects each to be certified in early 2008.
“This capacity expansion and addition to Ebei’s product mix has been long-anticipated and represents an important milestone for Benda,” commented Mr. Yiqing Wan, Benda Chairman & CEO. “Gendicine® has deservedly garnered most of the public’s attention of late, but much of the drug’s future growth will be made possible by the continued success of our stable, profitable product lines. Our investment in the Ebei plant will ultimately yield an even stronger base from which to launch Gendicine® into India and beyond.”
Stace
About Benda Pharmaceutical, Inc. BPMA BPMA BPMA
Benda Pharmaceutical, Inc. (www.bendapharma.com), a China-based pharmaceutical company, is a pure play on explosive Chinese pharmaceutical spending and the global search for a cancer cure. Benda produces traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer.
Stace
I have no idea how I got the .06s, but glad I did.
Stace
Followers
|
11
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
643
|
Created
|
08/26/07
|
Type
|
Free
|
Moderators |
On May 21, Benda Pharma (BPMA.OB) reported revenue of $3 million for Q1 of 2007, a decrease of 17% from the year-earlier period. Benda blamed the decrease on a temporary closing of its bulk chemical plant, a closing undertaken at the behest of the Chinese government, which mandated a cleanup of the wastewater of the plant. The plant is scheduled to be back online in August of this year.
Net income dropped to $0.4 million for the quarter, a decline of 51%. Besides the plant closing, Benda said it encountered additional expenses associated with being a public company. Benda has 96.3 million shares outstanding and, at its current price of $1.70 per share, it has a market capitalization of $164 million.
Benda is involved in making western and Traditional Chinese Medications, and it manufactures active pharmaceutical ingredients.
Quote:
http://www.bendapharma.com/stockquote.cfm
http://www.stockcharts.com/c-sc/sc?s=BPMA&p=D&yr=0&mn=5&dy=0&i=p68304234748&r=6802
In April of 2007, Benda bought a 57.57% ownership in Shenzhen SiBiona, which produces the cancer drug Gendicine, the first gene therapy medication for cancer available anywhere in the world. In 2004, Gendicine was approved by Chinese officials for use against head and neck cancer, which is also known as squamous cell cancer. The drug is injected once per week for eight weeks. In the Chinese trials, it achieved a complete remission in 64% of the cases and a partial remission in 32% of the patients. Gendicine was originally priced at $362 per injection.
To buy the stake in SiBiono, Benda paid $7.7 million and gave SiBiono 2.1 million shares of Benda stock in return for financial consulting services. Benda also guaranteed that its shares would be worth $3.60 per share within three months after the expiration of the 12-month restriction on selling the shares.
Benda operates three plants in the Hubei Province of China: Benda Ebei, which produces conventional medicines and Traditional Chinese Medicines; Jiangling Benda, which produces active pharmaceutical; and Yidu Benda, which produces bulk chemicals.
INSTITUTIONAL OWNERSHIP
Pope Investments LLC owns 22,337,998 shares accounting for 21.24% of shares outstanding!!
pinksheets.com/edgar/GetFilingHtml
SHARE STRUCTURE
As of August 19, 2009:
Shares Outstanding:105,155,355
Shares Authorized:150,000,000
[img]stockcharts.com/c-sc/sc?s=bpma&p=d&b=5&g=0&id=p86819233489[/img]
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |